Indeed, with increased circulating iron, if FGF23 has effects on reducing local or systemic oxidative stress (Czaya & Faul, 2019) then a suppression of FGF23 to levels that would elevate serum phosphate during CKD may further negatively influence bone properties. The gene discussed is FGF23; the disease is chronic kidney disease.